Cho levels were found to be further elevated in mutant tumours when compared to WT, a measurement validated via LC-MS, and a finding in line with previous studies that have examined metabolome-wide alterations seen in IDH mutated tumours [8,53]. The gene discussed is IDH2; the disease is neoplasm.